Resveratrol: Effects on Lipids and Cardiovascular Risk

Evan Paul Cherniack, Bruce R. Troen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

For several decades, there has been increasing interest in the possible use of resveratrol as a preventative agent in cardiovascular disease. Resveratrol exerts numerous effects on adipocyte, hepatocyte, and endothelial cell development and function. Many investigations have demonstrated the ability of resveratrol to regulate the adipocyte lifecycle, lipid synthesis, and improve hepatic lipid metabolism. Resveratrol has numerous vascular protective effects on endothelial tissue, including its antiplatelet activity. Resveratrol also reduces intracellular oxidative stress. Animal models of obesity and cardiovascular diseases have yielded important contributions to our understanding of the effects of resveratrol on the vasculature and the risk for pathology. In limited human studies, resveratrol reduces the release of proinflammatory cytokines and improves systemic glucose and insulin regulation and decreases cellular oxidative stress. Therefore, resveratrol has significant potential as both a prophylactic and treatment agent. However additional studies are required to more completely characterize its impacts on human physiology and its benefits in the setting of disease.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalCurrent Cardiovascular Risk Reports
Volume7
Issue number1
DOIs
StatePublished - Jan 21 2013

Fingerprint

Lipids
Adipocytes
Oxidative Stress
Cardiovascular Diseases
resveratrol
Lipid Metabolism
Endothelium
Blood Vessels
Hepatocytes
Endothelial Cells
Animal Models
Obesity
Insulin
Pathology
Cytokines
Glucose
Liver

Keywords

  • Adipocytes
  • Cardiovascular disease
  • Inflammation
  • Lipids
  • Oxidative stress
  • Resveratrol

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Resveratrol : Effects on Lipids and Cardiovascular Risk. / Cherniack, Evan Paul; Troen, Bruce R.

In: Current Cardiovascular Risk Reports, Vol. 7, No. 1, 21.01.2013, p. 9-16.

Research output: Contribution to journalArticle

@article{add19b852fa4410bb5e8178fb69c3514,
title = "Resveratrol: Effects on Lipids and Cardiovascular Risk",
abstract = "For several decades, there has been increasing interest in the possible use of resveratrol as a preventative agent in cardiovascular disease. Resveratrol exerts numerous effects on adipocyte, hepatocyte, and endothelial cell development and function. Many investigations have demonstrated the ability of resveratrol to regulate the adipocyte lifecycle, lipid synthesis, and improve hepatic lipid metabolism. Resveratrol has numerous vascular protective effects on endothelial tissue, including its antiplatelet activity. Resveratrol also reduces intracellular oxidative stress. Animal models of obesity and cardiovascular diseases have yielded important contributions to our understanding of the effects of resveratrol on the vasculature and the risk for pathology. In limited human studies, resveratrol reduces the release of proinflammatory cytokines and improves systemic glucose and insulin regulation and decreases cellular oxidative stress. Therefore, resveratrol has significant potential as both a prophylactic and treatment agent. However additional studies are required to more completely characterize its impacts on human physiology and its benefits in the setting of disease.",
keywords = "Adipocytes, Cardiovascular disease, Inflammation, Lipids, Oxidative stress, Resveratrol",
author = "Cherniack, {Evan Paul} and Troen, {Bruce R.}",
year = "2013",
month = "1",
day = "21",
doi = "10.1007/s12170-012-0289-2",
language = "English",
volume = "7",
pages = "9--16",
journal = "Current Cardiovascular Risk Reports",
issn = "1932-9520",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Resveratrol

T2 - Effects on Lipids and Cardiovascular Risk

AU - Cherniack, Evan Paul

AU - Troen, Bruce R.

PY - 2013/1/21

Y1 - 2013/1/21

N2 - For several decades, there has been increasing interest in the possible use of resveratrol as a preventative agent in cardiovascular disease. Resveratrol exerts numerous effects on adipocyte, hepatocyte, and endothelial cell development and function. Many investigations have demonstrated the ability of resveratrol to regulate the adipocyte lifecycle, lipid synthesis, and improve hepatic lipid metabolism. Resveratrol has numerous vascular protective effects on endothelial tissue, including its antiplatelet activity. Resveratrol also reduces intracellular oxidative stress. Animal models of obesity and cardiovascular diseases have yielded important contributions to our understanding of the effects of resveratrol on the vasculature and the risk for pathology. In limited human studies, resveratrol reduces the release of proinflammatory cytokines and improves systemic glucose and insulin regulation and decreases cellular oxidative stress. Therefore, resveratrol has significant potential as both a prophylactic and treatment agent. However additional studies are required to more completely characterize its impacts on human physiology and its benefits in the setting of disease.

AB - For several decades, there has been increasing interest in the possible use of resveratrol as a preventative agent in cardiovascular disease. Resveratrol exerts numerous effects on adipocyte, hepatocyte, and endothelial cell development and function. Many investigations have demonstrated the ability of resveratrol to regulate the adipocyte lifecycle, lipid synthesis, and improve hepatic lipid metabolism. Resveratrol has numerous vascular protective effects on endothelial tissue, including its antiplatelet activity. Resveratrol also reduces intracellular oxidative stress. Animal models of obesity and cardiovascular diseases have yielded important contributions to our understanding of the effects of resveratrol on the vasculature and the risk for pathology. In limited human studies, resveratrol reduces the release of proinflammatory cytokines and improves systemic glucose and insulin regulation and decreases cellular oxidative stress. Therefore, resveratrol has significant potential as both a prophylactic and treatment agent. However additional studies are required to more completely characterize its impacts on human physiology and its benefits in the setting of disease.

KW - Adipocytes

KW - Cardiovascular disease

KW - Inflammation

KW - Lipids

KW - Oxidative stress

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=84872283843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872283843&partnerID=8YFLogxK

U2 - 10.1007/s12170-012-0289-2

DO - 10.1007/s12170-012-0289-2

M3 - Article

AN - SCOPUS:84872283843

VL - 7

SP - 9

EP - 16

JO - Current Cardiovascular Risk Reports

JF - Current Cardiovascular Risk Reports

SN - 1932-9520

IS - 1

ER -